Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Drug discovery based on glycomics, (the study of complex sugars) Groundbreaking application in the area of developing generic biologics. CHP II was founding investor, June 2004 IPO. Co-Investors: Polaris, Atlas, MVM, Mithra.